A complete application in a minute
Tailored resume and cover letter, ready to send.
GSK's Extended Characterization Europe team is looking for an Analytical Scientist to support analytical development and characterization of biopharmaceutical molecules. This role primarily operates in the lab, employing LC-MS and LC-MS/MS to generate insights guiding drug substance and product development.
You will collaborate with Discovery and CMC Development, plan and interpret experiments, and communicate findings with rigor while ensuring data integrity and safety.
Join GSK's Extended Characterization Europe team as an Analytical Scientist, supporting the analytical development and characterisation of biopharmaceutical molecules. This predominantly laboratory-based role will use LC-MS and LC-MS/MS to generate scientific understanding that supports the development and control of new drug substances and products.
You will work independently and collaboratively across Discovery and CMC Development teams, combining strong scientific judgement, data analysis, communication and organisation to help deliver a novel pipeline of medicines to patients.
We create a place where people can grow, be their best, be safe, and feel welcome, valued and included. We offer a competitive salary, an annual bonus based on company performance, healthcare and wellbeing programmes, pension plan membership, and shares and savings programme.
We embrace modern work practises; our Performance with Choice programme offers a hybrid working model, empowering you to find the optimal balance between remote and in-office work.
Discover more about our company wide benefits and life at GSK on our webpage Life at GSK | GSK
Location: For candidates seeking to be located at our Stevenage site, this role will temporarily be based at Stevenage. However, the Company plans to relocate its offices to Ware. The location of this role will therefore subsequently change to Ware in accordance with timelines to be set by the Company. The relocation is currently proposed to take effect by early 2029.
Closing Date for Applications - 23rd November 2026 (COB)
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people's lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our